| | | | | New frontiers of ophthalmology - Part II
| | | By
Massimo Lombardi, MD
,
Patrizia Belilli, MD
| | | In the second of a two-part article Drs Lombardi and Belilli present the results of a patient suffering with a wet maculopathy affecting both eyes.
| | | New treatment for wet AMD
| | | By
Gary C. Brown, MD, MBA
,
Melissa M. Brown, MD, MN, MBA
| | | Evaluation of a new value-based treatment approach for wet AMD.
| |
| | | | Gene-directed therapy in glaucoma may have future clinical applications
| | | By
Nancy Groves
,
Wallace L.M Alward, MD
| | | Application of genetic knowledge holds huge potential for the future and some believe that it has potential to become larger than the pharmaceutical market. Here Dr Alward examines what it has offered for the understanding and future treatment of glaucoma. Until recently, breakthroughs in glaucoma genetics emerged from painstaking family research, with the discovery of LOXL1 being the exception.
| | | Canaloplasty: An expert's point of view
| | | By
Richard A. Lewis, MD
| | | A question and answer session with a canaloplasty expert.
| |
| | | | Out with the old and in with the new
| | | By
Ilya Petrou, MD
,
Alan Tomlinson PhD, DSc, FCOptom
| | | A comparison of an older nanoliter osometer and a newer osometer shows that both devices are effective in measuring tear osmolarity and produce comparable measurements.
| | | Insert improves symptoms and quality of life for patients with dry eye
| | | The use of hydroxypropyl cellulose can significantly improve the symptoms of dry eye, resulting in increased quality of life.
| | | Cyclosporine helps revent progression of dry eye
| | | By
Ilya Petrou, MD
,
Sanjay Rao, MD
| | | A recent study showed that moderate to sever dr eye disease can be best treated with anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can significantly limit progression of dry eye disease and should be considered a 'go-to' therapy for this patient population.
| | | New options in treating lid wiper epitheliopathy
| | | An oil-in-water and a corticosteroid were both effective in eliminating the signs and symptoms of lid wiper epitheliopathy after a 1-month active treatment phase in a recent study. Improvement was effectively maintained with the emollient eye drops in all patients over a 12-month period.
| | | Intraductal meibomian gland probing reduces inflammation
| | | A new technique of intraductal meibomian gland probing using disposable cannulas of various lengths appears highly effective in providing quick and lasting relief from inflammatory sysmptoms of obstructive meibomian gland disease.
| |
| | | | Accommodative IOL implantation: An expert's point of view
| | | By
Mark Tomalla, MD
| | | An interview with Dr Mark Tomalla about his experience with the Crystalens HD IOL.
| | | A new approach to multifocal lens technology
| | | By
Professor Gerd Auffarth
| | | Professor Auffarth of Heidelberg University Eye Clinic reports on the results of his implantation of the LENTIS Mplus and explains how the lens works using a new unique optical principle.
| | | The patients' new perspective
| | | Patients share their postoperative experiences and the dramatic changes in their lives bought about by undergoing refractive lens surgery. Patients had either high myopia, hyperopia and/or severe astigmatism and each received the AT.LISA 366D, a one-piece, 4 haptic multifocal IOL and each has found a new lease of life.
| |
| | | | The brains behind the BAD
| | | By
Michael W. Belin, MD
,
Renato Ambrosio Jr, MD, PhD
| | | Drs Belin and Ambrosio's Enhanced Ectasia module is a keratoconus index, based on pachy
| |
|
|
| 
